LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma.

Saved in:
Bibliographic Details
Title: LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma.
Authors: Gur C; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel; Rheumatology Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Wang SY; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel. Electronic address: shuangyinwang@me.com., Sheban F; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Zada M; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Li B; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Kharouf F; Rheumatology Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Peleg H; Rheumatology Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Aamar S; Rheumatology Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Yalin A; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Kirschenbaum D; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Braun-Moscovici Y; Rheumatology Institute, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israeli Institute of Technology, Haifa, Israel., Jaitin DA; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Meir-Salame T; Flow Cytometry Unit, Department of Biological Services, Weizmann Institute, Rehovot, Israel., Hagai E; Flow Cytometry Unit, Department of Biological Services, Weizmann Institute, Rehovot, Israel., Kragesteen BK; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Avni B; Department of Bone Marrow Transplantation, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Grisariu S; Department of Bone Marrow Transplantation, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Bornstein C; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Shlomi-Loubaton S; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., David E; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Shreberk-Hassidim R; Dermatology Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Molho-Pessach V; Dermatology Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Amar D; Plastic Surgery Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Tzur T; Plastic Surgery Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Kuint R; Institue of Pulmonology Medicine, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Gross M; Orthopedic Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Barboy O; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Moshe A; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Fellus-Alyagor L; The Department of Veterinary Resources, Weizmann Institute, Rehovot, Israel., Hirsch D; The Department of Veterinary Resources, Weizmann Institute, Rehovot, Israel., Addadi Y; Life Sciences Core Facilities, Weizmann Institute, Rehovot, Israel., Erenfeld S; Department of Bone Marrow Transplantation, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Biton M; Department of Biological Regulation, Weizmann Institute, Rehovot, Israel., Tzemach T; Rheumatology Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Elazary A; Rheumatology Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Naparstek Y; Rheumatology Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel., Tzemach R; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel; Rheumatology Institute at the Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel., Weiner A; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Giladi A; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel., Balbir-Gurman A; Rheumatology Institute, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israeli Institute of Technology, Haifa, Israel., Amit I; Department of Systems Immunology, Weizmann Institute, Rehovot, Israel. Electronic address: ido.amit@weizmann.ac.il.
Source: Cell [Cell] 2022 Apr 14; Vol. 185 (8), pp. 1373-1388.e20. Date of Electronic Publication: 2022 Apr 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-4172
DOI:10.1016/j.cell.2022.03.011